路透9月21日 - 洛克希德·马丁公司 LMT.N 周一表示，已获得美国陆军价值高达12亿美元的合同，用于生产“精确打击导弹(PrSM)”的增量2型号。
PrSM是陆军新一代远程精确打击武器，旨在取代陆军战术导弹系统（ATACMS）。
洛克希德·马丁公司表示，此次授予合同是在该导弹“增量2型号”第二次成功试飞之后取得的，该试验展示了其打击移动海上目标的能力。
该合同的签署正值洛克希德公司因远程打击武器需求不断增长而加紧生产“精确打击导弹”之际。
今年3月，这家国防巨头与美国陆军签署了一份为期七年的协议，将年生产能力提升至550枚导弹。此前，该公司已于去年获得了一份价值49.4亿美元的陆军合同，且该武器在“史诗怒火”行动中首次投入实战。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.